EcoDrugPlus

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSAPEG00000006157
Gene Symbol: BCR
1 Cross references
209 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSAPEG00000004821
Gene Symbol: BTK
1 Cross references
204 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSAPEG00000011346
Gene Symbol: CCR9
1 Cross references
194 Possible Orthologues:

C-X-C Motif Chemokine Receptor 1

Ensembl ID : ENSAPEG00000006249
Gene Symbol: CXCR1
1 Cross references
275 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSAPEG00000013201
Gene Symbol: CFTR
1 Cross references
216 Possible Orthologues:

Dna (Cytosine-5-)-Methyltransferase 1

Ensembl ID : ENSAPEG00000010505
Gene Symbol: DNMT1
1 Cross references
212 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSAPEG00000007810
Gene Symbol: TOP1
1 Cross references
201 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSAPEG00000005374
Gene Symbol: TOP2A
1 Cross references
205 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSAPEG00000006606
Gene Symbol: TOP2B
1 Cross references
209 Possible Orthologues:

Dna Topoisomerase Ia

Ensembl ID : ENSAPEG00000023452
Gene Symbol: TOP1A
1 Cross references
208 Possible Orthologues:

Emap Like 4

Ensembl ID : ENSAPEG00000015691
Gene Symbol: EML4
2 Cross references
206 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSAPEG00000013027
Gene Symbol: EPHA3
1 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).